AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35807912 — intervention group
Group type: EXPERIMENTAL
Intervention: Early introduction of solid foods (10‐12th week corrected age)
Number of subjects: 177
Study 35807912 — intervention group
Group type: COMPARATOR
Intervention: Late introduction of solid foods (16‐18th week corrected age)
Number of subjects: 177
Study 32654610 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipsilateral familiarization
Number of subjects: 60
Study 32654610 — intervention group
Group type: EXPERIMENTAL
Intervention: Contralateral familiarization
Number of subjects: 60
Study 32654610 — intervention group
Group type: EXPERIMENTAL
Intervention: Left foot tested
Number of subjects: 60
Study 32654610 — intervention group
Group type: EXPERIMENTAL
Intervention: Right foot tested
Number of subjects: 60
Study 35080502 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemonitoring system with decision support
Number of subjects: 96
Study 35080502 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 96
Study 32979516 — intervention group
Group type: EXPERIMENTAL
Intervention: SOS-GR
Number of subjects: 8
Study 32979516 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D-DLCS
Number of subjects: 8
Study 32979516 — intervention group
Group type: EXPERIMENTAL
Intervention: TV-CS
Number of subjects: 8
Study 32979516 — intervention group
Group type: EXPERIMENTAL
Intervention: TV-BL-CS
Number of subjects: 8
Study 32979516 — intervention group
Group type: COMPARATOR
Intervention: NUFFT
Number of subjects: 8
Study 35993422 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced HR Only
Number of subjects: 41
Study 35993422 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced SpO2 Only
Number of subjects: 41
Study 35993422 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Both
Number of subjects: 41
Study 35993422 — intervention group
Group type: COMPARATOR
Intervention: No Enhancement
Number of subjects: 41
Study 33906807 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mL PRP intracavernosal injections, n = 30
Number of subjects: 60
Study 33906807 — intervention group
Group type: COMPARATOR
Intervention: Placebo intracavernosal injections, n = 30
Number of subjects: 60
Study 32601289 — intervention group
Group type: EXPERIMENTAL
Intervention: Mustard aphid (L. erysimi)
Number of subjects: 2
Study 32601289 — intervention group
Group type: COMPARATOR
Intervention: Cowpea aphid (A. craccivora)
Number of subjects: 2
Study 32762792 — intervention group
Group type: EXPERIMENTAL
Intervention: Art Therapy (AT)
Number of subjects: 49
Study 32762792 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 49
Study 33021404 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning model using preablation pulmonary vein computed tomography images for predicting NPV triggers
Number of subjects: 521
Study 34156769 — intervention group
Group type: EXPERIMENTAL
Intervention: mTBI
Number of subjects: 9428
Study 34156769 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 9428
Study 33448617 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Analytic Therapy (CAT)
Number of subjects: 79
Study 34333502 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% chlorhexidine
Number of subjects: 85
Study 34333502 — intervention group
Group type: COMPARATOR
Intervention: 10% iodine
Number of subjects: 85
Study 33894153 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of 600,000 IU of vitamin D3
Number of subjects: 630
Study 33894153 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 630
Study 32883721 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based intervention based on Acceptance and Commitment Therapy (ACT), 7 modules over 7 weeks, guided by a trained e-coach.
Number of subjects: 286
Study 32883721 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based intervention based on Acceptance and Commitment Therapy (ACT)
Number of subjects: 286
Study 32883721 — intervention group
Group type: COMPARATOR
Intervention: Enhanced treatment as usual (TAU+)
Number of subjects: 286
Study 36149205 — intervention group
Group type: EXPERIMENTAL
Intervention: pQLB
Number of subjects: 90
Study 36149205 — intervention group
Group type: EXPERIMENTAL
Intervention: pTAPB
Number of subjects: 90
Study 36149205 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 90
Study 33263286 — intervention group
Group type: EXPERIMENTAL
Intervention: Movement Matters Activity Program (MMAP)
Number of subjects: 0
Study 33263286 — intervention group
Group type: EXPERIMENTAL
Intervention: MMAP implementation strategies
Number of subjects: 0
Study 33263286 — intervention group
Group type: EXPERIMENTAL
Intervention: MMAP training and resources
Number of subjects: 0
Study 33263286 — intervention group
Group type: EXPERIMENTAL
Intervention: MMAP implementation
Number of subjects: 0
Study 33263286 — intervention group
Group type: EXPERIMENTAL
Intervention: Successful MMAP implementation
Number of subjects: 0
Study 34257088 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured pharmacotherapy optimisation intervention
Number of subjects: 2008
Study 34257088 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 2008
Study 34197339 — intervention group
Group type: EXPERIMENTAL
Intervention: Homeopathic treatment (Berberis 6CH, Mercurius Solubilis/Belladona/Hepar Sulfur, Pyrogenium 200CH biotherapic) prescribed in diluted low ultra-diluted concentration doses for all signs and symptoms, with biotherapics used for chronic stimulation.
Number of subjects: 85
Study 34197339 — intervention group
Group type: COMPARATOR
Intervention: Control group (Conventional periodontal therapy without homeopathy)
Number of subjects: 85
Study 33025229 — intervention group
Group type: EXPERIMENTAL
Intervention: Below-knee compression garment (CG) during exercise (100 maximal isokinetic eccentric contractions)
Number of subjects: 24
Study 33025229 — intervention group
Group type: COMPARATOR
Intervention: Control group (CONCG: CG, no exercise)
Number of subjects: 24
Study 33025229 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise without CG (EXP)
Number of subjects: 24
Study 36279373 — intervention group
Group type: EXPERIMENTAL
Intervention: Supravenous laser blood irradiation, pulsed magnetotherapy, dry-air carbon dioxide baths, structured therapeutic exercises in the gym.
Number of subjects: 60
Study 36279373 — intervention group
Group type: COMPARATOR
Intervention: Standard elastic compression (compression class 2-3) and lymphovenotonics (diosmin and hesperidin) with therapeutic exercises in the gym.
Number of subjects: 60
Study 33153828 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine (300 mg nightly)
Number of subjects: 130
Study 33153828 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study 33153828 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 130
Study 33153828 — intervention group
Group type: COMPARATOR
Intervention: Quetiapine and Placebo
Number of subjects: 130
Study 35245446 — intervention group
Group type: EXPERIMENTAL
Intervention: Toripalimab plus paclitaxel plus cisplatin (TP)
Number of subjects: 514
Study 35245446 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus paclitaxel plus cisplatin (TP)
Number of subjects: 514
Study 36062743 — intervention group
Group type: EXPERIMENTAL
Intervention: Netakimab (120 mg subcutaneous at weeks 0, 1, 2, and every other week thereafter)
Number of subjects: 228
Study 36062743 — intervention group
Group type: EXPERIMENTAL
Intervention: Netakimab
Number of subjects: 228
Study 36062743 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 228
Study 32140705 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV13 (2015-2017)
Number of subjects: 30000
Study 32140705 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV7/PCV13 implementation
Number of subjects: 30000
Study 34738962 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational Physical Activity (OPA)
Number of subjects: 11
Study 34738962 — intervention group
Group type: COMPARATOR
Intervention: Rest (REST)
Number of subjects: 11
Study 34066659 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous education program with 10 themes during 2017–2018
Number of subjects: 85
Study 34066659 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 85
Study 33036921 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline 400 mg, three times daily, for 9 doses within 72 hours of diagnosis
Number of subjects: 83
Study 33036921 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study 33036921 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline
Number of subjects: 83
Study 32631713 — intervention group
Group type: EXPERIMENTAL
Intervention: WALANT
Number of subjects: 185
Study 36229048 — intervention group
Group type: EXPERIMENTAL
Intervention: Otilimab 90 mg plus standard care
Number of subjects: 1156
Study 36229048 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus standard care
Number of subjects: 1156
Study 32920677 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline EQ-5D score at 0 week
Number of subjects: 166
Study 32920677 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline VAS for low back pain at 0 week
Number of subjects: 166
Study 32920677 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 166
Study 32920677 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluid-intensity T2-weighted MR image patterns
Number of subjects: 166
Study 32376815 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise program using an elastic band for 8 weeks, 3 days a week
Number of subjects: 72
Study 32376815 — intervention group
Group type: COMPARATOR
Intervention: Normal daily activities for 8 weeks
Number of subjects: 72
Study 34563635 — intervention group
Group type: COMPARATOR
Intervention: Standard parotid-sparing radiation therapy
Number of subjects: 102
Study 34563635 — intervention group
Group type: EXPERIMENTAL
Intervention: Stem cell sparing (SCS) radiation therapy
Number of subjects: 102
Study 34563635 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 102
Study 33620899 — intervention group
Group type: EXPERIMENTAL
Intervention: Spanish-translated survey
Number of subjects: 30
Study 33620899 — intervention group
Group type: COMPARATOR
Intervention: Cognitive interviews
Number of subjects: 30
Study 34391941 — intervention group
Group type: EXPERIMENTAL
Intervention: Brain development claim
Number of subjects: 2190
Study 34391941 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunity-related claim
Number of subjects: 2190
Study 34391941 — intervention group
Group type: COMPARATOR
Intervention: Control claim (new and improved)
Number of subjects: 2190
Study 34196379 — intervention group
Group type: EXPERIMENTAL
Intervention: No-suction
Number of subjects: 323
Study 34196379 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mL suction
Number of subjects: 323
Study 34196379 — intervention group
Group type: COMPARATOR
Intervention: 20 mL suction
Number of subjects: 323
Study 34898293 — intervention group
Group type: EXPERIMENTAL
Intervention: Menopausal hormone therapy (MHT) with exercise and education
Number of subjects: 132
Study 34898293 — intervention group
Group type: COMPARATOR
Intervention: Placebo with exercise and education
Number of subjects: 132
Study 34898293 — intervention group
Group type: EXPERIMENTAL
Intervention: Tendon-specific exercise
Number of subjects: 132
Study 34898293 — intervention group
Group type: EXPERIMENTAL
Intervention: Sham exercise
Number of subjects: 132
Study 33373538 — intervention group
Group type: EXPERIMENTAL
Intervention: Advance Care Planning (ACP) intervention
Number of subjects: 198
Study 33373538 — intervention group
Group type: EXPERIMENTAL
Intervention: ACP decision aid
Number of subjects: 198
Study 33373538 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-intervention ACP conversations
Number of subjects: 198
Study 34330211 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower limb resistance exercise for 12 weeks
Number of subjects: 60
Study 34330211 — intervention group
Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 60
Study 33055176 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus $40 bonus programme
Number of subjects: 4172
Study 33055176 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus no bonus programme
Number of subjects: 4172
Study 33055176 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 4172
Study 33055176 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus team based programmes
Number of subjects: 4172
Study 33055176 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus individual based programmes
Number of subjects: 4172
Study 33055176 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus $20 bonus programme
Number of subjects: 4172
Study 33526383 — intervention group
Group type: EXPERIMENTAL
Intervention: e-GW
Number of subjects: 588
Study 33526383 — intervention group
Group type: COMPARATOR
Intervention: GW-C
Number of subjects: 588
Study 35608484 — intervention group
Group type: EXPERIMENTAL
Intervention: Liberal approach to glucose control (IV insulin commenced at blood glucose >252 mg/dl, titrated to 180-252 mg/dl)
Number of subjects: 419
Study 35608484 — intervention group
Group type: COMPARATOR
Intervention: Control approach to glucose control (IV insulin commenced at blood glucose >180 mg/dl, titrated to 108-180 mg/dl)
Number of subjects: 419
Study 34022750 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical capsaicin (0.075%)
Number of subjects: 37
Study 34022750 — intervention group
Group type: COMPARATOR
Intervention: Non-sensitizing placebo (Lubriderm)
Number of subjects: 37
Study 33288086 — intervention group
Group type: EXPERIMENTAL
Intervention: Tazarotene 0.05% gel with NB-UVB
Number of subjects: 30
Study 36370871 — intervention group
Group type: EXPERIMENTAL
Intervention: Relugolix combination therapy (40 mg relugolix, 1 mg estradiol, and 0.5 mg norethindrone acetate once daily)
Number of subjects: 509
Study 36370871 — intervention group
Group type: EXPERIMENTAL
Intervention: Relugolix combination therapy
Number of subjects: 509
Study 36370871 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 509
Study 33591141 — intervention group
Group type: EXPERIMENTAL
Intervention: SA with morphine 0.1 mg (SA0.1)
Number of subjects: 510
Study 33591141 — intervention group
Group type: EXPERIMENTAL
Intervention: SA with morphine 0.2 mg (SA0.2)
Number of subjects: 510
Study 33591141 — intervention group
Group type: EXPERIMENTAL
Intervention: Fascia iliaca compartment block with dexamethasone 4 mg + levobupivacaine 0.375% 20 mL (FICB20)
Number of subjects: 510
Study 33591141 — intervention group
Group type: EXPERIMENTAL
Intervention: Fascia iliaca compartment block with dexamethasone 4 mg + levobupivacaine 0.375% 30 mL (FICB30)
Number of subjects: 510
Study 33591141 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral femoral cutaneous nerve block with levobupivacaine 0.25% 5 mL (LFCNB)
Number of subjects: 510
Study 33591141 — intervention group
Group type: EXPERIMENTAL
Intervention: FICB20 + LFCNB
Number of subjects: 510
Study 33591141 — intervention group
Group type: COMPARATOR
Intervention: Standardized analgesia (intravenous metamizole magnesium, dexketoprofen, paracetamol, morphine, regional rescue)
Number of subjects: 510
Study 36183378 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-pulsed alexandrite laser (LPAL) plus low-fluence Nd:YAG
Number of subjects: 27
Study 36183378 — intervention group
Group type: COMPARATOR
Intervention: Pulsed-dye laser (PDL)
Number of subjects: 27
Study 36183378 — intervention group
Group type: COMPARATOR
Intervention: Comparison of LPAL and PDL
Number of subjects: 27
Study 33731314 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Theta-burst Stimulation (TBS)
Number of subjects: 20
Study 33731314 — intervention group
Group type: COMPARATOR
Intervention: Sham Theta-burst Stimulation (TBS)
Number of subjects: 20
Study 32858301 — intervention group
Group type: EXPERIMENTAL
Intervention: Intimate partner violence educational intervention based on World Health Organization guidelines
Number of subjects: 104
Study 36349772 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram prediction model for cardiovascular events
Number of subjects: 1138
Study 36349772 — intervention group
Group type: EXPERIMENTAL
Intervention: External validation of the nomogram
Number of subjects: 1138
Study 33387220 — intervention group
Group type: EXPERIMENTAL
Intervention: Filmed research-based drama (Fit for Dialysis) + 16-week exercise program
Number of subjects: 19
Study 33387220 — intervention group
Group type: COMPARATOR
Intervention: 16-week exercise program (Control)
Number of subjects: 19
Study 32273234 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel chemotherapy
Number of subjects: 1050
Study 34475035 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly myopic eyes
Number of subjects: 175
Study 34475035 — intervention group
Group type: COMPARATOR
Intervention: Non-highly myopic eyes
Number of subjects: 175
Study 32974672 — intervention group
Group type: EXPERIMENTAL
Intervention: IVM (In-vitro maturation)
Number of subjects: 546
Study 32974672 — intervention group
Group type: COMPARATOR
Intervention: IVF (In-vitro fertilization)
Number of subjects: 546
Study 32974672 — intervention group
Group type: EXPERIMENTAL
Intervention: IVM
Number of subjects: 546
Study 32974672 — intervention group
Group type: COMPARATOR
Intervention: IVF
Number of subjects: 546
Study 35343658 — intervention group
Group type: EXPERIMENTAL
Intervention: Humidified warm CO2 insufflation
Number of subjects: 40
Study 35343658 — intervention group
Group type: COMPARATOR
Intervention: Dry cold CO2 insufflation
Number of subjects: 40
Study 34555516 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindful awareness
Number of subjects: 288
Study 34555516 — intervention group
Group type: EXPERIMENTAL
Intervention: Willingness
Number of subjects: 288
Study 34555516 — intervention group
Group type: EXPERIMENTAL
Intervention: Values
Number of subjects: 288
Study 32771596 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesh removal with analysis of mesh-tissue explants and standardized questionnaires including VAS pelvic pain scores.
Number of subjects: 30
Study 32771596 — intervention group
Group type: COMPARATOR
Intervention: Nonresponders to mesh removal treatment.
Number of subjects: 30
Study 32771596 — intervention group
Group type: EXPERIMENTAL
Intervention: Pathway analysis of tissue samples.
Number of subjects: 30
Study 34964149 — intervention group
Group type: EXPERIMENTAL
Intervention: 16 mg galantamine (acute administration)
Number of subjects: 50
Study 35725017 — intervention group
Group type: EXPERIMENTAL
Intervention: Postpartum diabetes screening (2-hour oral glucose tolerance test within 4-12 weeks postpartum)
Number of subjects: 1642
Study 35725017 — intervention group
Group type: COMPARATOR
Intervention: Postpartum diabetes screening
Number of subjects: 1642
Study 35725017 — intervention group
Group type: COMPARATOR
Intervention: Elevated risk for type 2 diabetes
Number of subjects: 1642
Study 35725017 — intervention group
Group type: COMPARATOR
Intervention: Perinatal depression
Number of subjects: 1642
Study 35725017 — intervention group
Group type: COMPARATOR
Intervention: Preterm delivery
Number of subjects: 1642
Study 35725017 — intervention group
Group type: COMPARATOR
Intervention: Parity ≥2 children
Number of subjects: 1642
Study 35725017 — intervention group
Group type: COMPARATOR
Intervention: Less than college education
Number of subjects: 1642
Study 35725017 — intervention group
Group type: COMPARATOR
Intervention: Chinese Americans
Number of subjects: 1642
Study 35725017 — intervention group
Group type: COMPARATOR
Intervention: Routine postpartum visit attendance
Number of subjects: 1642
Study 35725017 — intervention group
Group type: COMPARATOR
Intervention: Healthcare provider advice about screening
Number of subjects: 1642
Study 34266927 — intervention group
Group type: EXPERIMENTAL
Intervention: Esophageal temperature probe placed at the time of surgery
Number of subjects: 44
Study 34266927 — intervention group
Group type: COMPARATOR
Intervention: No esophageal temperature probe placed
Number of subjects: 44
Study 34975007 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (Severity Score ≥ 5)
Number of subjects: 0
Study 32320465 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad26.RSV.preF low-dose (LD; 5 × 10^10 vector particles)
Number of subjects: 72
Study 32320465 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad26.RSV.preF high-dose (HD; 1 × 10^11 vector particles)
Number of subjects: 72
Study 32320465 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 35181515 — intervention group
Group type: EXPERIMENTAL
Intervention: PediGuard device (impedancemetry-guided pedicle sighting)
Number of subjects: 16
Study 35181515 — intervention group
Group type: COMPARATOR
Intervention: Free-hand sighting (control group)
Number of subjects: 16
Study 33924952 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher genetically predicted eicosapentaenoic acid levels
Number of subjects: 337129
Study 33924952 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher genetically predicted dihomo-gamma-linolenic acid levels
Number of subjects: 337129
Study 33924952 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher allele scores for linoleic acid levels
Number of subjects: 337129
Study 33924952 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher linoleic acid levels (summary-level MR)
Number of subjects: 337129
Study 33924952 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher arachidonic acid levels
Number of subjects: 337129
Study 35781888 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-day protocol of systemic antibiotics (amoxicillin and metronidazole) 500mg 3-times-daily for 3 days, followed by placebo 3-times-daily for 4 days
Number of subjects: 50
Study 35781888 — intervention group
Group type: COMPARATOR
Intervention: 7-day protocol of systemic antibiotics (amoxicillin and metronidazole) 500mg 3-times-daily for 7 days
Number of subjects: 50
Study 33176232 — intervention group
Group type: EXPERIMENTAL
Intervention: Trastuzumab combined with taxanes (eBC)
Number of subjects: 21119
Study 33176232 — intervention group
Group type: EXPERIMENTAL
Intervention: Pertuzumab (first-line therapy)
Number of subjects: 21119
Study 33176232 — intervention group
Group type: COMPARATOR
Intervention: Trastuzumab–taxane (first-line therapy)
Number of subjects: 21119
Study 33176232 — intervention group
Group type: EXPERIMENTAL
Intervention: T-DM1 (second-line treatment)
Number of subjects: 21119
Study 33176232 — intervention group
Group type: EXPERIMENTAL
Intervention: First-line treatment for mBC
Number of subjects: 21119
Study 33176232 — intervention group
Group type: EXPERIMENTAL
Intervention: Second-line treatment for mBC
Number of subjects: 21119